Abstract
Using Icelandic whole-genome sequence data and an imputation approach we searched for rare sequence variants in CHRNA4 and tested them for association with nicotine dependence. We show that carriers of a rare missense variant (allele frequency=0.24%) within CHRNA4, encoding an R336C substitution, have greater risk of nicotine addiction than non-carriers as assessed by the Fagerstrom Test for Nicotine Dependence (P=1.2 x 10(-4)). The variant also confers risk of several serious smoking-related diseases previously shown to be associated with the D398N substitution in CHRNA5. We observed odds ratios (ORs) of 1.7-2.3 for lung cancer (LC; P=4.0 x 10(-4)), chronic obstructive pulmonary disease (COPD; P=9.3 x 10(-4)), peripheral artery disease (PAD; P=0.090) and abdominal aortic aneurysms (AAAs; P=0.12), and the variant associates strongly with the early-onset forms of LC (OR=4.49, P=2.2 x 10(-4)), COPD (OR=3.22, P=2.9 x 10(-4)), PAD (OR=3.47, P=9.2 x 10(-3)) and AAA (OR=6.44, P=6.3 x 10(-3)). Joint analysis of the four smoking-related diseases reveals significant association (P=6.8 x 10(-5)), particularly for early-onset cases (P=2.1 x 10(-7)). Our results are in agreement with functional studies showing that the human alpha4beta2 isoform of the channel containing R336C has less sensitivity for its agonists than the wild-type form following nicotine incubation.
